Aarti Pharmalabs Limited — Updates, 01-04-2025: Amendment(s)

Aarti Pharmalabs Limited has executed an Addendum to its Subscription and Shareholders’ Agreement, formalizing a joint venture with Ganesh Polychem Limited, effective from March 31, 2025. This agreement does not grant any special rights to the involved parties or entail a fresh issuance of shares. Consequently, APL will start consolidating financial statements using the equity method beginning April 1, 2025. This strategic partnership signals an expansion move, potentially enhancing APL's market position and operational capabilities. Investor sentiment may lean positively, viewing the venture as an opportunity for growth and increased shareholder value.